4-chloro-7-nitrobenzofurazan has been researched along with Symptom Cluster in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bevers, EM; Comfurius, P; Schlegel, RA; Schroit, AJ; Sims, PJ; Smeets, EF; Weiss, HJ; Wiedmer, T; Williamson, P; Zhao, J; Zwaal, RF | 1 |
Bevers, EM; Christie, A; Comfurius, P; Harmsma, M; Kohlin, T; Schlegel, RA; Williamson, P; Zwaal, RF | 1 |
2 other study(ies) available for 4-chloro-7-nitrobenzofurazan and Symptom Cluster
Article | Year |
---|---|
The complex of phosphatidylinositol 4,5-bisphosphate and calcium ions is not responsible for Ca2+-induced loss of phospholipid asymmetry in the human erythrocyte: a study in Scott syndrome, a disorder of calcium-induced phospholipid scrambling.
Topics: 4-Chloro-7-nitrobenzofurazan; Calcium; Erythrocyte Membrane; Erythrocytes; Hemophilia A; Humans; In Vitro Techniques; Kinetics; Lipid Bilayers; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositol Phosphates; Phospholipids; Reference Values; Syndrome; Thromboplastin | 1995 |
Phospholipid scramblase activation pathways in lymphocytes.
Topics: 4-Chloro-7-nitrobenzofurazan; Animals; Apoptosis; B-Lymphocytes; Blood Coagulation Disorders; Calcium; Carrier Proteins; Cell Line, Transformed; Enzyme Activation; Flow Cytometry; Humans; Hybridomas; Jurkat Cells; Lymphocytes; Membrane Proteins; Mice; Mutation; Phosphatidylcholines; Phosphatidylserines; Phospholipid Transfer Proteins; Phospholipids; Spectrometry, Fluorescence; Syndrome | 2001 |